Time-averaged hemoglobin values, not hemoglobin cycling, have an impact on outcomes in pediatric dialysis patients


BAKKALOĞLU EZGÜ S. A. , Kandur Y., Serdaroglu E., Noyan A., KARABAY BAYAZIT A., Tasdemir M., ...More

PEDIATRIC NEPHROLOGY, vol.33, no.11, pp.2143-2150, 2018 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 33 Issue: 11
  • Publication Date: 2018
  • Doi Number: 10.1007/s00467-018-4013-4
  • Title of Journal : PEDIATRIC NEPHROLOGY
  • Page Numbers: pp.2143-2150

Abstract

During erythropoietin-stimulating agent (ESA) treatment, hemoglobin (Hb) levels usually fluctuate; this phenomenon is known as "Hb cycling (HC)." In this study, we aimed to evaluate the predictors of HC and its impact on left ventricular hypertrophy (LVH) as a patient-important outcome parameter in pediatric dialysis patients.